Condition: GERD (Gastroesophageal Reflux Disease) · Sponsor: Gerd Care Medical Ltd
The purpose of this research is to evaluate the safety and effectiveness of the eGERD device, which is a novel device for treating Gastroesophageal Reflux Disease (GERD). The main questions this research aims to answer are: 1. Does the eGERD device reduce acidity in the esophagus? 2. Does the eGERD device reduce GERD symptoms such as heartburn and regurgitation? 3. What medical problems do participants have when using the eGERD device? To assess the acidity in the esophagus, a wireless standard-of-care capsule called Bravo will be placed in the participants esophagus (throat) for several days. To assess GERD symptoms, participants will be requested to report symptoms they experience using a smartphone application. Researchers will compare a real version of the eGERD device to a sham version (a look-alike device that has no therapeutic effect) to see if the eGERD device is effective in treating GERD.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Division of Gastroenterology & Hepatology Feinberg School of Medicine Northwestern University | Chicago, Illinois, United States | Not Yet Recruiting |
| Gastroenterology department, Emek medical center (EMC) | Afula, Israel | Recruiting |
| Gastroenterology department, Rambam Health Care Campus | Haifa, Israel | Recruiting |
| Gastroenterology department, Rabin medical center (RMC) | Petah Tikva, Israel | Recruiting |
| Gastroenterology department, Tel Aviv Sourasky Medical Center (Ichilov) | Tel Aviv, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06613438